Autoimmune and autoinflammatory mechanisms in uveitis
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The eye, as currently viewed, is neither immunologically ignorant nor sequestered from the systemic environment. The eye utilises distinct immunoregulatory mechanisms to preserve tissue and cellular function in the face of immune-mediated insult; clinically, inflammation following such an insult is termed uveitis. The intra-ocular inflammation in uveitis may be clinically obvious as a result of infection (e.g. toxoplasma, herpes), but in the main infection, if any, remains covert. We now recognise that healthy tissues including the retina have regulatory mechanisms imparted by control of myeloid cells through receptors (e.g. CD200R) and soluble inhibitory factors (e.g. alpha-MSH), regulation of the blood retinal barrier, and active immune surveillance. Once homoeostasis has been disrupted and inflammation ensues, the mechanisms to regulate inflammation, including T cell apoptosis, generation of Treg cells, and myeloid cell suppression in situ, are less successful. Why inflammation becomes persistent remains unknown, but extrapolating from animal models, possibilities include differential trafficking of T cells from the retina, residency of CD8(+) T cells, and alterations of myeloid cell phenotype and function. Translating lessons learned from animal models to humans has been helped by system biology approaches and informatics, which suggest that diseased animals and people share similar changes in T cell phenotypes and monocyte function to date. Together the data infer a possible cryptic infectious drive in uveitis that unlocks and drives persistent autoimmune responses, or promotes further innate immune responses. Thus there may be many mechanisms in common with those observed in autoinflammatory disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 1×
“disease [143–147].”
The bone marrow niche for haematopoietic stem cells
Morrison, S. J., & Scadden, D. T. (2014) · Nature · doi:10.1038/nature12984 · Cited by 2,451 · cited 1×
“Complex interactions may be critical to maintaining these environments, where many different cell types can regulate niches both directly and indirectly, and where hematopoietic stem cell traffic in and out of the niches is reported [41].”
BackgroundBendall, S. C., Simonds, E. F., Qiu, P., Amir, E.-A. D., Krutzik, P. O., Finck, R., Bruggner, R. V., Melamed, R., Trejo, A., Ornatsky, O. I., et al. (2011) · Science · doi:10.1126/science.1198704 · Cited by 2,279
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862 · cited 1×
“the periphery, access to the immune privileged ocular environment may be under the control of vessel-associated antigen presentation, in a fashion analogous to that described in the brain [51].”
BackgroundJäger, A., Dardalhon, V., Sobel, R. A., Bettelli, E., & Kuchroo, V. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901906 · Cited by 783 · cited 1×
“of different T cell phenotypes has been evaluated [62].”
BackgroundDynamic regulatory network controlling TH17 cell differentiation
Yosef, N., Shalek, A. K., Gaublomme, J. T., Jin, H., Lee, Y., Awasthi, A., Wu, C., Karwacz, K., Xiao, S., Jorgolli, M., et al. (2013) · Nature · doi:10.1038/nature11981 · Cited by 682 · cited 1×
“When naive CD4 T helper cells are activated, they reorganise transcriptional networks [52].”
Effector T cell plasticity: flexibility in the face of changing circumstances
Murphy, K. M., & Stockinger, B. (2010) · Nature Immunology · doi:10.1038/ni.1899 · Cited by 482 · cited 1×
“This leads them to assume different functional phenotypes, often characterised by the secretion of signature cytokines [53, 54].”
BackgroundTh17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation
Peters, A., Pitcher, L. A., Sullivan, J. M., Mitsdoerffer, M., Acton, S. E., Franz, B., Wucherpfennig, K., Turley, S., Carroll, M. C., Sobel, R. A., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.10.015 · Cited by 480 · cited 1×
“through IL-17 produced from Th17 cells; [64]).”
Dendritic cell physiology and function in the eye
Forrester, J. V., Xu, H., Kuffová, L., Dick, A. D., & McMenamin, P. G. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00873.x · Cited by 195 · cited 2×
“maintain immune health of these tissues [69].”
BackgroundSelf-citationKerr, E. C., Raveney, B. J. E., Copland, D. A., Dick, A. D., & Nicholson, L. B. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.08.006 · Cited by 162 · cited 2×
“Autoimmune diseases such as multiple sclerosis within these tissues radically alter the local dynamics of immune cell trafficking within the affected tissue [28].”
BackgroundSelf-citationThrombospondin Plays a Vital Role in the Immune Privilege of the Eye
Zamiri, P., Masli, S., Kitaichi, N., Taylor, A. W., & Streilein, J. W. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0362 · Cited by 143
Deckert, M., Sedgwick, J. D., Fischer, E., & Schlüter, D. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0062-z · Cited by 82
Chu, C. J., Herrmann, P., Carvalho, L. S., Liyanage, S. E., Bainbridge, J. W. B., Ali, R. R., Dick, A. D., & Luhmann, U. F. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063002 · Cited by 60 · cited 2×
“and T cell accumulations in later disease [17].”
BackgroundSelf-citationCopland, D. A., Liu, J., Schewitz-Bowers, L. P., Brinkmann, V., Anderson, K., Nicholson, L. B., & Dick, A. D. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.008 · Cited by 50 · cited 2×
“166], and by inhibiting trafficking of cells [34, 35, 167].”
BackgroundMethodSelf-citationFingolimod (FTY720) as an acute rescue therapy for intraocular inflammatory disease
Raveney, B. J. E., Copland, D. A., Nicholson, L. B., & Dick, A. D. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.10.1390 · Cited by 39
Self-citationTerrada, C., Fisson, S., De Kozak, Y., Kaddouri, M., Lehoang, P., Klatzmann, D., Salomon, B. L., & Bodaghi, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7171 · Cited by 38
Cited by
Retinal microglia initiate neuroinflammation in ocular autoimmunity
Okunuki, Y., Mukai, R., Nakao, T., Tabor, S. J., Butovsky, O., Dana, R., Ksander, B. R., & Connor, K. M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820387116 · Cited by 216
Treatment of uveitis by in situ administration of ex vivo–activated polyclonal regulatory T cells
Grégoire, S., Terrada, C., Martin, G. H., Fourcade, G., Baeyens, A., Marodon, G., Fisson, S., Billiard, F., Lucas, B., Tadayoni, R., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501723 · Cited by 33
Metadata
- Authors
- Lee, R. W., Nicholson, L. B., Sen, H. N., Chan, C.-C., Wei, L., Nussenblatt, R. B., & Dick, A. D.
- Venue
- Seminars in Immunopathology
- Published
- 2014-05-24
- Volume
- 36
- Issue
- 5
- Pages
- 581-594
- ISSN
- 1863-2297 (ISSN-L)
- 1863-2300
- OpenAlex
- W1997972850
- Cited by
- 186
- References
- 16
- FWCI
- 9.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.